Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caraballo R. S., Giovino G. A., Pechacek T. F., Mowery P. D., Richter P. A., Strauss W. J., Sharp D. J., Eriksen M. P., Pirkle J. L., Maurer K. R. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998 Jul 8;280(2):135–139. doi: 10.1001/jama.280.2.135. [DOI] [PubMed] [Google Scholar]
- Cohen C. J., Iwane M. K., Palensky J. B., Levin D. L., Meagher K. J., Frost K. R., Mayer K. H. A national HIV community cohort: design, baseline, and follow-up of the AmFAR Observational Database. American Foundation for AIDS Research Community-Based Clinical Trials Network. J Clin Epidemiol. 1998 Sep;51(9):779–793. doi: 10.1016/s0895-4356(98)00043-2. [DOI] [PubMed] [Google Scholar]
- Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation. Am J Med Sci. 1999 Jan;317(1):5–8. doi: 10.1097/00000441-199901000-00002. [DOI] [PubMed] [Google Scholar]
- Dennis G. C. NMA's clinical trials program. J Natl Med Assoc. 1998 Dec;90(12):743–744. [PMC free article] [PubMed] [Google Scholar]
- Gamble V. N. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997 Nov;87(11):1773–1778. doi: 10.2105/ajph.87.11.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorelick P. B., Richardson D., Hudson E., Perry C., Robinson D., Brown N., Harris Y. Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience. J Natl Med Assoc. 1996 Nov;88(11):701–704. [PMC free article] [PubMed] [Google Scholar]
- Jamerson K., DeQuattro V. The impact of ethnicity on response to antihypertensive therapy. Am J Med. 1996 Sep 30;101(3A):22S–32S. doi: 10.1016/s0002-9343(96)00265-3. [DOI] [PubMed] [Google Scholar]
- Johnson J. A. Influence of race or ethnicity on pharmacokinetics of drugs. J Pharm Sci. 1997 Dec;86(12):1328–1333. doi: 10.1021/js9702168. [DOI] [PubMed] [Google Scholar]
- Kalow W. Interethnic variation of drug metabolism. Trends Pharmacol Sci. 1991 Mar;12(3):102–107. doi: 10.1016/0165-6147(91)90516-u. [DOI] [PubMed] [Google Scholar]
- Lin K. M., Poland R. E., Wan Y. J., Smith M. W., Lesser I. M. The evolving science of pharmacogenetics: clinical and ethnic perspectives. Psychopharmacol Bull. 1996;32(2):205–217. [PubMed] [Google Scholar]
- Matthews H. W. Racial, ethnic and gender differences in response to medicines. Drug Metabol Drug Interact. 1995;12(2):77–91. doi: 10.1515/dmdi.1995.12.2.77. [DOI] [PubMed] [Google Scholar]
- Ojo A. O., Port F. K., Held P. J., Wolfe R. A., Turenne M. N., Chung E., Mauger E. A., Leichtman A. B. Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection. Kidney Int. 1995 Nov;48(5):1592–1599. doi: 10.1038/ki.1995.452. [DOI] [PubMed] [Google Scholar]
- Osei K., Schuster D. P., Owusu S. K., Amoah A. G. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans. Metabolism. 1997 Jan;46(1):53–58. doi: 10.1016/s0026-0495(97)90167-0. [DOI] [PubMed] [Google Scholar]
- Prisant L. M. Calcium antagonists--pharmacologic considerations. Ethn Dis. 1998 Winter;8(1):98–102. [PubMed] [Google Scholar]
- Robinson S. B., Ashley M., Haynes M. A. Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health. 1996 Apr;21(2):77–87. doi: 10.1007/BF01682300. [DOI] [PubMed] [Google Scholar]
- Shamanin V., zur Hausen H., Lavergne D., Proby C. M., Leigh I. M., Neumann C., Hamm H., Goos M., Haustein U. F., Jung E. G. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst. 1996 Jun 19;88(12):802–811. doi: 10.1093/jnci/88.12.802. [DOI] [PubMed] [Google Scholar]
- Shavers-Hornaday V. L., Lynch C. F., Burmeister L. F., Torner J. C. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health. 1997 Mar-Jun;2(1-2):31–45. doi: 10.1080/13557858.1997.9961813. [DOI] [PubMed] [Google Scholar]
- Smith M. W., Mendoza R. P. Ethnicity and pharmacogenetics. Mt Sinai J Med. 1996 Oct-Nov;63(5-6):285–290. [PubMed] [Google Scholar]
- Strickland T. L., Lin K. M., Fu P., Anderson D., Zheng Y. Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biol Psychiatry. 1995 Mar 1;37(5):325–330. doi: 10.1016/0006-3223(94)00133-N. [DOI] [PubMed] [Google Scholar]
- Svensson C. K. Representation of American blacks in clinical trials of new drugs. JAMA. 1989 Jan 13;261(2):263–265. [PubMed] [Google Scholar]
- Weir M. R. Population characteristics and the modulation of the renin-angiotensin system in the treatment of hypertension. J Hum Hypertens. 1997 Jan;11(1):17–21. doi: 10.1038/sj.jhh.1000395. [DOI] [PubMed] [Google Scholar]
- Weir M. R., Saunders E. Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. Trandolapril Multicenter Study Group. J Hum Hypertens. 1998 Mar;12(3):189–194. doi: 10.1038/sj.jhh.1000578. [DOI] [PubMed] [Google Scholar]
- Wood A. J. Ethnic differences in drug disposition and response. Ther Drug Monit. 1998 Oct;20(5):525–526. doi: 10.1097/00007691-199810000-00013. [DOI] [PubMed] [Google Scholar]
- Wood A. J., Zhou H. H. Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet. 1991 May;20(5):350–373. doi: 10.2165/00003088-199120050-00002. [DOI] [PubMed] [Google Scholar]
- Zahm S. H., Fraumeni J. F., Jr Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ Health Perspect. 1995 Nov;103 (Suppl 8):283–286. doi: 10.1289/ehp.95103s8283. [DOI] [PMC free article] [PubMed] [Google Scholar]